Hosted by OLLI and the WVU Committee of Retired Faculty, James J. Mahoney will discuss early findings from clinical trials conducted on neuromodulation for addiction at WVU and the Rockefeller Neuroscience Institute at 2:30 p.m June 4 at the Mountaineer Mall, OLLI Classroom B and on Zoom.
He will also discuss other technologies developed, such as population health digital infrastructure that utilizes wearable technology and other health data, combined with machine learning to monitor, identify and predict risk factors associated with drug relapse.
Mahoney is the director of addictions research at the RNI and previously served as chair of the Research Oversight Committee. He has accumulated more than 20 years of research experience, most of which has focused on the assessment and treatment of substance use disorders. His specific areas of research focus include the investigation of various forms of neuromodulation, such as deep brain stimulation, focused ultrasound and transcranial magnetic stimulation for the treatment of substance use disorders and other behavioral/psychiatric indications.
He completed his doctoral training at the University of Houston and specialized postdoctoral training in neuropsychology at the University of Virginia
The lecture is free and open to the public.